Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 27 of 27 publications.

Colacci M, Raissi A, Ray P, Sholzberg M, Rothman KJ, Fralick M. Randomized controlled trials of switching to a new medication vs continuing a chronic medication may underestimate the risk of adverse events in those continuing because of asymmetric depletion of susceptibles. J Clin Epidemiol. 2024 Jun;170:111336. doi: 10.1016/j.jclinepi.2024.111336

Pajouheshnia R, van Smeden M, Peelen LM, Groenwold RHH. How variation in predictor measurement affects the discriminative ability and transportability of a prediction model. J Clin Epidemiol. 2019 Jan;105:136-41. doi: 10.1016/j.jclinepi.2018.09.001

Groenwold RHH, Moons KGM, Pajouheshnia R, Altman DG, Collins GS, Debray TPA, Reitsma JB, Riley RD, Peelen LM. Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings. J Clin Epidemiol. 2016 Oct;78:90-100. doi: 10.1016/j.jclinepi.2016.03.017

DiBenedetti DB, Brown TM, Danchenko N. Assessing patient and caregiver experiences with symptoms and behaviors associated with schizophrenia. J Depress Anxiety. 2016 Jul 17;5(3):240. doi: 10.4200/2167-1044.1000240

Brown TM, DiBenedetti DB, Danchenko N, Weiller E, Fava M. Symptoms of anxiety and irritability in patients with major depressive disorder. J Depress Anxiety. 2016 Jun 18;5:237. doi: 10.4200/2167-1044.1000237

Boccia S, Rothman KJ, Panic N, Flacco ME, Rosso A, Pastorino R, Manzoli L, La Vecchia C, Villari P, Boffetta P, Ricciardi W, Ioannidis JP. Registration practices for observational studies on ClinicalTrials.gov indicated low adherence. J Clin Epidemiol. 2016 Feb;70:176-82. doi: 10.1016/j.jclinepi.2015.09.009

Risko R, Merdan S, Womble PR, Barnett C, Ye Z, Linsell SM, Montie JE, Miller DC, Denton BT. Clinical predictors and recommendations for staging computed tomography scan among men with prostate cancer. Urology. 2014 Dec;84(6):1329-34. doi: 10.1016/j.urology.2014.07.051

Merdan S, Womble PR, Miller DC, Barnett C, Ye Z, Linsell SM, Montie JE, Denton BT. Toward better use of bone scans among men with early-stage prostate cancer. Urology. 2014 Oct;84(4):793-8. doi: 10.1016/j.urology.2014.06.010

McKenna SP, Twiss J, Crawford SR, Oprandi NC, Tammaru M, Miravitlles M. The living with chronic obstructive pulmonary disease scale was successfully adapted for use in southern european (Italian and Spanish) and eastern european (Russian) cultures. J Clin Epidemiol. 2012 Aug;65(8):906-14.

Bernfort L, Brodtkorb T. QALY som effektmått inom vården : möjligheter och begränsningar. Linköping: linköping University Electronic Press. Cmt- Rapport. 2012.

Stang A, Rothman KJ. That confounded P-value revisited. J Clin Epidemiol. 2011 Sep 1;64(9):1047-8.

Brodtkorb T. National system for assessment, prioritization and introduction of non-pharmaceutical health technologies, a pilot study. Cmt- Rapport. 2010.

Nørgaard M, Wogelius P, Pedersen L, Rothman KJ, Sørensen HT. Maternal use of oral contraceptives during early pregnancy and risk of hypospadias in male offspring. Urology. 2009 Sep;74(3):583-7.

Stuermer T, Rothman KJ, Avorn J. Pharmacoepidemiology and "in silico" drug evaluation: is there common ground? J Clin Epidemiol. 2008 Mar 1;61(3):205-6.

Drummond FJ, Sharp L, Carsin AE, Kelleher T, Comber H. Questionnaire order significantly increased response to a postal survey sent to primary care physicians. J Clin Epidemiol. 2008 Feb;61(2):177-85. doi: 10.1016/j.jclinepi.2007.04.012

Sturmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol. 2006 May 1;59(5):437-47.

Wincze J, Rosen R, Carson C, Korenman S, Niederberger C, Sadovsky R, McLeod L, Thibonnier M, Merchant S. Erection quality scale: initial scale development and validation. Urology. 2004 Aug 1;64(2):351-6.

Carnethon MR, Anthony MS, Cascio WE, Folsom AR, Rautaharju PM, Liao D, Evans GW, Heiss G. Prospective association between hormone replacement therapy, heart rate, and heart rate variability. The Atherosclerosis risk in communities study. J Clin Epidemiol. 2003 Jun;56(6):565-71.

Cella D, Eton DT, Faircloth DL, Bonomi P, Heyes AE, Silberman C, Wolf MK, Johnson DH. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy - Lung (FACT-L) questionnaire? Results from Eastern Cooperative Group (ECOG) Study 5592. J Clin Epidemiol. 2002 Mar;55(3):285-95.

Rothman KJ. My actual beliefs. J Clin Epidemiol. 2001 Dec 1;54(12):1275. doi: 10.1016/S0895-4356(01)00419-X

Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology. 2000 Aug 1;56(2):302-6.

Kleinman KP, Feldman HA, Johannes CB, Derby CA, McKinlay JB. A new surrogate variable for erectile dysfunction status in the Massachusetts Male Aging Study. J Clin Epidemiol. 2000 Jan 1;53(1):71-8.

Johannes CB, Stellato RK, Feldman HA, Longcope C, McKinlay JB. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study. J Clin Epidemiol. 1999 Feb;52(2):95-103.

Brambilla DJ, McKinlay SM, McKinlay SR, Weiss SR, Johannes CB, Crawford SL, Longcope C. Does collecting repeated blood samples from each subject improve the precision of estimated steroid hormone levels? J Clin Epidemiol. 1996 Mar;49(3):345-50.

Rothman KJ. The ethics of research sponsorship. J Clin Epidemiol. 1991 Jan 1;44(Suppl 1):S25-8.

Lanes SF, Rothman KJ. Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome. J Clin Epidemiol. 1990 Jan 1;43(12):1379-85.

Poole C, Rothman KJ. Epidemiologic science and public health policy. J Clin Epidemiol. 1990 Jan 1;43(11):1270-1. doi: 10.1016/0895-4356(90)90029-O